Omega Diagnostics Group (ODX)

 

Latest News

Omega Diagnostics sees FY adj. pretax profit at £1.1m

Omega Diagnostics says its FY results will be in line with market views, with revenues seen at 14.3m and adjusted profit be...

Trading Update and Notice of Results

RNS Number: 1774D Omega Diagnostics Group PLC 25 April 2017 Omega Diagnostics Group PLC ("Omega" or "the Company") Trading Update and Notice of Results Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that results for the year to 31 March 2017 will be in line with market expec...

Holding(s) in Company

RNS Number: 0156D Omega Diagnostics Group PLC 21 April 2017 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii Omega Diagnostics Group plc 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of votin...

VISITECT? Malaria CE-Mark & Indian FDA inspection

RNS Number: 8169A Omega Diagnostics Group PLC 29 March 2017 Omega Diagnostics Group PLC ("Omega" or the "Company") VISITECT Malaria CE-Mark and successful Indian FDA inspection Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it has CE-Marked its VISITECT range o...

All News

DateHeadlineSource
25-04-17Omega Diagnostics sees FY adj. pretax profit at £1.1mStockMarketWire
25-04-17Trading Update and Notice of ResultsRNS
21-04-17Holding(s) in CompanyRNS
29-03-17VISITECT? Malaria CE-Mark & Indian FDA inspectionRNS
07-03-17Holding(s) in CompanyRNS
27-02-17Holding(s) in CompanyRNS
27-01-17Omega Diagnostics update on talks with IDSStockMarketWire
27-01-17Update on discussions with IDSRNS
11-01-17ISO accreditation for manufacturing facilityRNS
29-11-16Hardman Research: Food intolerance driving growthRNS
24-11-16Holding(s) in CompanyRNS
21-11-16Omega Diagnostics improves H1 pretax profitStockMarketWire
21-11-16Half-year ReportRNS
31-10-16Hardman Research: Diagnosing growth opportunitiesRNS
17-10-16Trading Update and Notice of Interim ResultsRNS
10-08-16Result of AGMRNS
02-08-16Omega Diagnostics secures £1.8m R&D grantStockMarketWire
02-08-16R&D Grant FundingRNS
04-07-16Holding(s) in CompanyRNS
01-07-16Holding(s) in CompanyRNS
27-06-16Omega pre-tax profit down to £1.35mStockMarketWire
27-06-16Final ResultsRNS
09-06-16Holding(s) in CompanyRNS
21-04-16Omega Diagnostics sees FY results in line with viewsStockMarketWire
21-04-16Trading Update & Notice of ResultsRNS
08-02-16Holding(s) in CompanyRNS
04-12-15Holding(s) in CompanyRNS
03-12-15Holding(s) in CompanyRNS
30-11-15Omega Diagnostics' H1 pretax profit slipsStockMarketWire
30-11-15Half Yearly ReportRNS
26-10-15Trading Update and Notice of Interim ResultsRNS
30-09-15Grant of OptionsRNS
07-09-15Omega resolutions passed at AGM StockMarketWire
07-09-15Result of AGMRNS
07-07-15FTSE falls on Greece spectre as miners plummetStockMarketWire
07-07-15Should I Sell Shire plc & Buy Omega Diagnostics Group plc Right Now?Motley Fool
07-07-15FTSE fades to noon on supermarkets, house buildiersStockMarketWire
07-07-15FTSE ekes out slim gains as MKS, NG. in focusStockMarketWire
07-07-15Omega's profitStockMarketWire
07-07-15Final ResultsRNS

RSS feeds

  • Editorial news feed for LSE:ODX Editorial
  • Regulatory news feed for LSE:ODX Regulatory